Wechselwirkungen · Riltrava Aerosphere
Riltrava Aerosphere 5 micrograms/14.4 micrograms/160 micrograms pressurised inhalation, suspension · Abschnitt 4.5 · PDF-Seite 21
HOS-146210 · Präparat HOS-099464
Since glycopyrronium is eliminated mainly by the renal route, drug interaction could potentially occur with medicinal products affecting renal excretion mechanisms. In vitro, glycopyrronium is a substrate for the renal transporters OCT2 and MATE1/2K. The effect of cimetidine, a probe inhibitor of OCT2 and MATE1, on inhaled glycopyrronium disposition showed a limited increase in its total systemic exposure (AUC0-t) by 22% and a slight decrease in renal clearance by 23% due to co-administration of cimetidine.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): cimetidine (HOS-085835) glycopyrronium (HOS-125830)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-02T16:35:00Z · SHA-256 2c3c1f837c02fb01a9b23f0bee262799934d841507f0e523790d6c8028b6fe72 · Passage 349145855e734c16764a490e9885d03fcbeca9b65f4c09321e23bd2feecf88c2 · Zeichen 1358–1870 im Abschnitt